Gujarat Terce Laboratories Limited

₹46.30As of Sun 8 Nov 2026, 12:00 UTC
BSE:524314Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 18.57%
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.82
PE TTM 18.06
TSR TTM 1.20%
Mkt cap ₹360.7M
ROIC 40.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹55
17.87%
74.04%
Hold 1|5|2|10|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.00
1.10
1.10
1.12
22.26%
22.28%
12.00%
17.19%
Revenue₹M
46.45
47.81
49.44
47.97
4.77%
5.87%
7.35%
2.50%
Peers (US$3.841M)
Cap (US$)
PE
4.146M
4.302x
Capital
TTM
5Y
10Y
Leveragex
0.441
0.148
0.152
EBIT/Intx
4.361
0.247
0.235
Own earn%
78.70
(28.54)
(23.47)
Sh yield%
40.89
17.79
19.00
Owners
Insiders/Inst%
11.19
85.87
Short interest%
4.13
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
3